Animated Storytelling for Colorectal Cancer Screening
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a short animated video can motivate people to get screened for colorectal cancer. Participants will either watch the animation or read a straightforward informational text. The goal is to determine which method more effectively encourages people to plan for screening. The trial seeks U.S. adults who haven't been screened for colorectal cancer and can read English. As an unphased trial, it offers participants a chance to contribute to innovative research that could enhance public health strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this animated storytelling method is safe for colorectal cancer screening?
Research shows that animated stories safely encourage colorectal cancer screening. No reports indicate problems from watching these videos. Designed to inform and motivate, they avoid causing harm. Studies have found that storytelling engages viewers, making information more relatable and easier to understand. This method has succeeded in various health campaigns, proving well-received and safe for participants.12345
Why are researchers excited about this trial?
Researchers are excited about using animated storytelling for colorectal cancer screening because it offers a fresh and engaging way to communicate important health information. Unlike traditional methods like pamphlets or spoken advice, animated videos can capture attention and simplify complex topics, making them more accessible and memorable. This approach could potentially increase screening rates by reducing fear and confusion about procedures like colonoscopies. By making the information more relatable and easier to understand, this method has the potential to encourage more people to participate in life-saving screenings.
What evidence suggests that animated storytelling is effective for increasing colorectal cancer screening?
Research has shown that storytelling can encourage people to get screened for colorectal cancer. In this trial, participants in one arm will view an animated storytelling video about colorectal cancer screening and colonoscopy. One study found that women who watched a storytelling video were more likely to plan an endoscopy and suggest it to others. Another study found that videos combined with text were more effective at encouraging cancer screening than text alone. Humor in stories also helps engage people who might otherwise avoid the topic. Overall, using stories seems to make people more likely to take action on health screenings.13678
Who Is on the Research Team?
Maya Adam, MD, PhD
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for adults in the U.S. who have not yet had colorectal cancer screening, can read and understand English, and are willing to give electronic consent.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants are exposed to either a brief animated storytelling video or a time-neutral informational text about colorectal cancer screening
Follow-up
Participants' behavioral expectations, knowledge, and perceptions about colorectal cancer screening are assessed immediately after exposure
What Are the Treatments Tested in This Trial?
Interventions
- Animated Storytelling
Trial Overview
The study compares a short animated storytelling video with an informational text to see which better encourages people to plan on getting screened for colorectal cancer. Participants are randomly assigned to one of the two groups online.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants view a brief animated storytelling video about colorectal cancer screening and colonoscopy.
Participants complete surveys only and receive no intervention.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
Heidelberg University
Collaborator
Citations
Animated Storytelling to Promote Colorectal Cancer ...
In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment.
Animated Storytelling to Promote Colorectal Cancer ...
This online randomized controlled trial will evaluate whether a short animated storytelling video increases behavioral expectation to obtain colorectal cancer ...
Comparative Effectiveness of Text + Video vs Text Alone to ...
Comparative Effectiveness of Text + Video vs Text Alone to Prompt Stool-Based Testing for Colorectal Cancer Screening. Amanda F Petrik ...
Humor may help engagement with colorectal cancer information
But new research led by UB suggests that humor can be an effective mechanism for reaching people who otherwise avoid information about ...
Qualitative Outcomes of Colorectal Cancer Screening ...
Among those with abnormal FITs, 50% received navigation, and 23% completed diagnostic colonoscopy. While higher-risk patients received navigation, none ...
Animated Storytelling for Colorectal Cancer Screening
This online randomized controlled trial will evaluate whether a short animated storytelling video increases behavioral expectation to obtain colorectal ...
How narratives influence colorectal cancer screening decision ...
“Outcome narratives” describe the psychological (eg, patient's quality of life or regret) or physical (eg, CRC patient's survival) health outcomes associated ...
Storytelling to Promote Colorectal Cancer Screening
The goal of this program is to use storytelling to increase colorectal cancer screening and improve nutrition and physical activity among underserved Latina ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.